Document is current
Any future updates will be listed below
-
Authors
Aliazis, Konstantinos https://orcid.org/0000-0003-1954-7914
Christofides, Anthos
Shah, Rushil
Yeo, Yao Yu
Jiang, Sizun https://orcid.org/0000-0001-6149-3142
Charest, Alain https://orcid.org/0000-0002-1548-6950
Boussiotis, Vassiliki A. https://orcid.org/0000-0002-3963-1518
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (RO1CA27161, R01CA238263, R01CA257672, RO1CA27161, R01NS130209, R21NS139480)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (DP2AI171139)
- License Information
-
More Information
Article History
Received: 25 August 2024
Accepted: 17 April 2025
First Online: 13 June 2025
Competing interests
: S.J. is a cofounder of Elucidate Bio and has received research support from Roche unrelated to this work. V.A.B. has patents on the PD-1 pathway licensed by Bristol Myers Squibb, Roche, Merck, EMD Serono, Boehringer Ingelheim, AstraZeneca, Novartis and Dako. The authors declare no other competing interests.
